Tegoprazan

Tegoprazan
Product Description

Tegoprazan is a novel patented Potassium-Competitive Acid Blocker (P-CAB) which alleviates the limitations of the historical Proton Pump Inhibitors (PPIs) and of other competing P-CABs. 

Tegoprazan's competitive advantages have been demonstrated via Phase 3 clinical studies conducted in Korea and Phase 1 clinical study from the US. 


Based on the outstanding achievements, Tegoprazan was approved by MFDS in 2019 under four (4) indications: Erosive Reflux Disease (ERD), Non-Erosive Gastro Esophageal Reflux Disease (NERD), Gastric Ulcer (GU) and Helicobacter pylori Eradication. 


Other than in South Korea, Tegoprazan received approval in China, Mongolia and Philippines among the 34 countries where HK inno.N has licensed out to.


HK inno.N is actively searching for business partners whom they can develop Tegoprazan in unpartnered counties. For further information, please contact Ga-Young Lee (BD, [email protected])

HK inno.N Corporation

  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2020
Company types
Pharmaceutical company

HK inno.N Corporation

  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2020
Company types
Pharmaceutical company

More Products from HK inno.N Corporation (6)

  • Exone-R Tab. (Valsartan/Amlodipine/Rosuvastatin)

    Product Exone-R Tab. (Valsartan/Amlodipine/Rosuvastatin)

    Exone-R is a fixed-dose triple combination therapy for patients with hypertension and dyslipidemia. It combines Valsartan and Amlodipine to help control blood pressure, along with Rosuvastatin to manage cholesterol levels. By addressing both cardiovascular risk factors in a single tablet, Exone-R supports ...
  • Omap One Inj / Omap Plus One Inj (TPN)

    Product Omap One Inj / Omap Plus One Inj (TPN)

    Omap One Peri is a three-chamber peripheral parenteral nutrition solution designed for patients who cannot receive sufficient nutrition orally or enterally. It provides essential nutrients, including glucose, amino acids, and lipids, to support energy needs and nutritional balance. The product can be admin...
  • Atomet XR Tab. (Atorvastatin + Metformin)

    Product Atomet XR Tab. (Atorvastatin + Metformin)

    Fixed Dose Combination drug, indicated for Type2 Diabetes with Hyperlipidemia with Clinical trials phase Ⅰ & Ⅲ

  • Calmtop RTU Inj. (Irinotecan)
  • Closone Cap. (Clopidogrel + Aspirin)

    Product Closone Cap. (Clopidogrel + Aspirin)

    Fixed Dose Combination drug, indicated for Atherosclerosis, thromboembolism
  • Silenor Tab. (Doxepine)

    Product Silenor Tab. (Doxepine)

    Insomnia, Non-addictive and helps staying asleep longer